United Services Automobile Association Cytom X Therapeutics, Inc. Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$7.38 - $12.25 $988,927 - $1.64 Million	-134,001 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$9.35 - $11.41 $17,484 - $21,336	-1,870 Reduced 1.38%	134,001 $1.5 Million
Q1 2019 May 13, 2019	BUY	$9.5 - $19.16 $47,709 - $96,221	5,022 Added 3.84%	135,871 $1.46 Million
Q4 2018 Feb 13, 2019	BUY	$12.69 - $18.61 $924,745 - $1.36 Million	72,872 Added 125.69%	130,849 $1.98 Million
Q3 2018 Nov 13, 2018	BUY	$18.04 - $26.41 $99,707 - $145,968	5,527 Added 10.54%	57,977 $1.07 Million
Q2 2018 Aug 10, 2018	SELL	$21.38 - $29.68 $30,167 - $41,878	-1,411 Reduced 2.62%	52,450 $1.2 Million
Q1 2018 May 14, 2018	BUY	$21.76 - $34.22 $549,679 - $864,431	25,261 Added 88.33%	53,861 $1.53 Million
Q4 2017 Feb 14, 2018	BUY	$19.0 - $23.09 $543,400 - $660,374	28,600	28,600 $604,000

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.